Philip W. Kantoff

Insider Reports History

Entity
Individual
Location
3675 Market Street, Suite 200, Philadelphia, PA
Signature
/s/ Alex Levit, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philip W. Kantoff:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ESSA Pharma Inc. Director Options 50K Mar 25, 2024 Direct
Context Therapeutics Inc. Director Stock Option (right to buy) 25K Jun 13, 2024 Direct

Insider Reports Filed by Philip W. Kantoff

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CNTX Context Therapeutics Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
EPIX ESSA Pharma Inc. Mar 25, 2024 1 $0 4 Mar 28, 2024 Director
CNTX Context Therapeutics Inc. May 31, 2023 1 $0 4 May 31, 2023 Director
EPIX ESSA Pharma Inc. Sep 13, 2022 0 $0 3 Sep 21, 2022 Director
CNTX Context Therapeutics Inc. Jun 2, 2022 1 $0 4 Jun 3, 2022 Director
CNTX Context Therapeutics Inc. Oct 19, 2021 0 $0 3 Oct 19, 2021 Director